Morgan Stanley, Leerink Partners, Cantor and Wells Fargo Securities acted as joint book-running managers for the offering. Baird and Oppenheimer & Co. acted as co-lead managers for the offering.

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on OR Royalties (OR – Research Report) and Alumis Inc. (ALMS – Research Report). C ...

National philanthropist, best-selling author, award-winning filmmaker, acclaimed speaker, and global media executive, Dr. Cheryl Polote Williamson, will honor 17 Black women business owners and ...

Detailed price information for Commercial Metals Company (CMC-N) from The Globe and Mail including charting and trades.

Alumis Inc. is drawing attention with a major share sale and bullish analyst forecasts. The firm aims to fund its immune ...

From Genye Gewog in Thimphu to other districts, Chizhi Goenpa mask dancers are keeping a centuries-old tradition alive. They ...

Alumis (ALMS) has drawn fresh attention after reporting positive topline Phase 3 ONWARD results for envudeucitinib in moderate to severe plaque psoriasis. All primary and secondary endpoints were met, ...

In addition, Alumis has granted the underwriters a 30-day option to purchase up to an additional 2,647,500 shares of common stock at the public offering price, less underwriting discounts and ...

Alumis (ALMS) has announced a public offering of 17.65M shares of common stock priced at $17.00 per share. This offering is ...

Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...

Alumis (ALMS) stock is soaring after the company announced positive trial results for its plaque psoriasis drug ...

Alumis said on Tuesday its experimental drug met the main goal of improving symptoms of a common skin disease in two late-stage studies, powering its shares to a record high and more than doubling ...